Search research articles
Contact Us
Filters
Showing results (221-230 of 241) with videos related to
Page
of 25
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 4, 2024
Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications
Dilara Akbulut, Karissa Whiting, Min-Yuen Teo, et al.
European Urology
|
May 13, 2026
IDH1 Mutations Are Associated with Favorable Outcomes in Prostate Cancer
Luka Cavka, Subhiksha Nandakumar, Qingqing Wu, et al.
American Journal of Cancer Research
|
September 15, 2021
Diagnosis of "cribriform" prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendations
Rajal B Shah, Qi Cai, Manju Aron, et al.
Histopathology
|
January 24, 2018
Utility of Pathology Imagebase for standardisation of prostate cancer grading
Lars Egevad, Brett Delahunt, Daniel M Berney, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 24, 2025
Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary Tract
Rayan Rammal, Florestan J Koll, Ziyu Chen, et al.
Nature Genetics
|
February 23, 2016
Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer
Hikmat A Al-Ahmadie, Gopa Iyer, Byron H Lee, et al.
Clinical Genitourinary Cancer
|
June 8, 2022
Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy
Min Yuen Teo, Brendan J Guercio, Arshi Arora, et al.
JCO Precision Oncology
|
June 22, 2022
Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype
Nima Almassi, Karissa Whiting, Antoun Toubaji, et al.
European Urology
|
April 27, 2025
Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma
Carissa E Chu, Ziyu Chen, Karissa Whiting, et al.
Cancer Cell
|
June 10, 2008
The role of SPINK1 in ETS rearrangement-negative prostate cancers
Scott A Tomlins, Daniel R Rhodes, Jianjun Yu, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 241) with videos related to
Sort By:
Page
of 25
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 4, 2024
Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications
Dilara Akbulut, Karissa Whiting, Min-Yuen Teo, et al.
European Urology
|
May 13, 2026
IDH1 Mutations Are Associated with Favorable Outcomes in Prostate Cancer
Luka Cavka, Subhiksha Nandakumar, Qingqing Wu, et al.
American Journal of Cancer Research
|
September 15, 2021
Diagnosis of "cribriform" prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendations
Rajal B Shah, Qi Cai, Manju Aron, et al.
Histopathology
|
January 24, 2018
Utility of Pathology Imagebase for standardisation of prostate cancer grading
Lars Egevad, Brett Delahunt, Daniel M Berney, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 24, 2025
Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary Tract
Rayan Rammal, Florestan J Koll, Ziyu Chen, et al.
Nature Genetics
|
February 23, 2016
Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer
Hikmat A Al-Ahmadie, Gopa Iyer, Byron H Lee, et al.
Clinical Genitourinary Cancer
|
June 8, 2022
Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy
Min Yuen Teo, Brendan J Guercio, Arshi Arora, et al.
JCO Precision Oncology
|
June 22, 2022
Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype
Nima Almassi, Karissa Whiting, Antoun Toubaji, et al.
European Urology
|
April 27, 2025
Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma
Carissa E Chu, Ziyu Chen, Karissa Whiting, et al.
Cancer Cell
|
June 10, 2008
The role of SPINK1 in ETS rearrangement-negative prostate cancers
Scott A Tomlins, Daniel R Rhodes, Jianjun Yu, et al.
Page
of 25